Budget 2024 – impact on your taxes, investments and markets

Union Budget 2024-25, the first Budget after Elections, has taken a slightly different tack after a long time. The focus on personal taxes is back – whether it is to give or take. While we admit there is probably a little more taking than giving, the simplification of tax, accompanied by more money in the hands of people through the New Tax Regime, together with sustained capex will still likely keep the economic growth engine chugging, along with the comfort of a fiscal deficit that is largely in control.

Budget 2024 – impact on your taxes, investments and markets

Budget 2024 Impact on Personal taxes

Continuing with the objective of incentivizing more people to join the simplified new tax regime, there were announcements to sweeten the new tax regime in this budget as well. While the overall number of slabs remains the same, there are some changes in the first three slabs, allowing less tax outgo. See the slabs in the new tax regime.

Additionally, the standard deduction under the new tax regime has been increased to Rs. 75,000 from Rs. 50,000 earlier, making another Rs. 25,000 tax-free.

We have created a new spreadsheet to help you assess whether you’re better off with the new or old tax regime after these recent changes. Please find it below.

Under Section 80CCD, for non-government employees, contributions to a pension plan like NPS from their employer were tax-deductible up to 10% of salary. This limit has now been increased to 14% under the new tax regime. Do note that the maximum employer contribution allowed under PF and NPS combined is Rs.7.5 lakh per year and there is no mention of revising this in the budget memorandum. This change is with effect from the assessment year 2025-2026 (FY 24-25).

Employers offering NPS as part of the salary package might tweak the salary structure to benefit from this change. Although section 80CCD is available under both the old and new tax regimes, the increase in exemption to pension contributions has been given only to the new tax regime. This is yet another evidence of making the new tax regime more attractive.

Chapter XVII of the Income Tax act deals with the collection and recovery of tax.  Under this chapter, portion B deals with tax deduction at source (TDS) and BB deals with tax collection at source (on sale of certain items for instance where the seller will collect tax from the buyer at specified rates and remit the same to the Government).

Section 192 that falls under Chapter XVII B covers TDS on salaries whereby an employer is liable to deduct tax on salary before paying the same out. This section also lays out how the amount of tax to be deducted is to be computed – taking into account all the income of the employee and not just the salary income, TDS and loss on income from house property. TCS was not taken into consideration.

If it turns out that too much tax was deducted on the salary, after taking into consideration all of the income, TDS and TCS of the assessee, he / she had to go through the hassle of claiming a refund. To make life simpler, this section, specifically sub-section 2B of this section, will be modified with effect from October 1, 2024 to state that in arriving at the tax to be deducted on salaries, the employer must take into account the following (subject of course to the employee submitting proof of the same):

1.       any income chargeable under any other head of income

2.       loss under ‘income from house property’

3.       any tax deducted or collected at source

In other words, TCS is now allowed to be set off against TDS liability on their salaried income.

If you are a young student and looking forward to your first job, Budget 2024 will give you some extra motivation. One of the focus areas of the Budget 2024 is ‘Employment and Skilling’ and three schemes have been announced under this. The ‘First Timers’ scheme or Scheme A, will certainly interest you! This promises one month’s wage to all new entrants in all formal sectors (based on EPFO registration). This will be paid in 3 instalments and will be capped at Rs. 15,000. The eligibility criteria for this benefit is a salary of up to Rs. 1 lakh per month.

Scheme B that is intended to incentivize job creation in the manufacturing sector too will interest you as it will provide a direct benefit to both the employer and you the new first-time employee on EPFO contributions for the first four years for specified scales.

Budget 2024 – Impact on investments

  • There were two big ticket announcements through the Union Budget that could impact you positively and negatively – depending on which asset class you are interested in. They are:  rationalization of capital gains tax and
  • increase in securities transaction tax on futures and options segment.

The former (capital gains) is a HUGE change. Let us deal with it first.

In a move to simplify capital gains across asset classes there have been four broad changes:

  • One, having only two holding period cut offs - 12 months or 24 months – to qualify for long term. All listed securities (read as listed equities and bonds) will be classified as long term if held for more than 1 year and all other asset classes will be classified as long term if held for more than 2 years.
  • Two, short term capital gains on stocks, equity funds and units of business trust (InvIT and REIT) is proposed to be taxed at 20% as against 15% earlier. For other instruments, STCG is the same as it is now.
  • Three, LTCG will be uniformly taxed at 12.5% for all classes of assets. How you define ‘Long Term’ will be based on point number 1 above.
  • Four, there will be no indexation benefit for any asset class

However, as a consolation, the total long term capital gains exemption for shares and equity-oriented funds has been increased from Rs 1 lakh to Rs 1.25 lakh per year. Now let us look into what this means for different asset classes.

Listed stocks, equity mutual funds and listed bonds

In the table below, the changes are

  • the STCG for shares and equity funds (from the present 15%),
  • LTCG for all the 3 instruments (from 10% to 12.5%) and
  • the holding period for REITs and InvITs that has changed from 36 months to 12 months.

What it means for you: Your LTCG incidence will go up from 10% to 12.5%. So, on a say Rs 10,000 gain, if you paid Rs 1,000 as LTCG it would now be Rs 1,250 or a 25% increased tax outflow. In STCG, this is even worse as it moves from 15% to 20%. The impact here is a 33% increase in tax outflow. But you need to keep in mind that the exemption on capital gains has increased from Rs 1 lakh to Rs 1.25 lakh for LTCG. The other positive is recognition of REITs and InvITs as LTCG if held for 12 months. Overall negative, especially for STCG.

Unlisted bonds, debentures and shares

In the table below, the holding period has reduced from 36 to 24 months for all the instruments mentioned. STCG has remained the same and LTCG is proposed at 12.5% from the present 20% with indexation.

What it means for you: Holding period reduction from 36 months to 24 months is a positive. The 12.5% taxation can largely be positive for unlisted shares and can go either way for unlisted bonds and debentures. Overall marginally positive.

Certain categories of mutual funds

As shown in the table below,

  • For equity Funds: Tax on STCG and LTCG have increased (from 15% and 10% respectively).
  • For debt-oriented and conservative hybrid funds: Nothing changes.
  • For gold, international and fund of funds (with less than 65% in debt): The definition of specified mutual funds has changed. Therefore, these will no longer be taxed like debt.

One class of product that we have not mentioned above is gold and silver ETFs and International ETFs. While the intent of the law appears to be to take them out of debt definition, it is unclear whether they will be considered as listed security for classifying as >12 month LTCG. One interpretation is that they will not fall under the debt category and are listed and should automatically be classified like equity for LTCG and STCG.

We think this may not be the case. In other words, for gold and International funds, holding period is likely >24 months for LTCG. STCG appears to be slab rate (as was the case before) and LTCG at a much better rate of 12.5% (slab rate at present). We will update this if the interpretation is otherwise.

The other contentious issue at present is whether debt funds will be taxed under 12.5% for their long term capital gains, considering that all assets other than the listed securities fall under 12.5%. Our understanding is that, this is not the case. A separate section 50AA was created last year only for the purpose of taxing debt funds separately. This section remains, albeit with a modified interpretation of what constitutes specified mutual funds.

What it means for you: For gold funds, international funds and FoF that are not into debt, the taxation makes these asset classes better than debt and hence a big positive.

Physical assets

The biggest change for the asset classes below is the removal of indexation benefit and change in taxation from 20% (with indexation) to 12.5% (without indexation). Please note that this move is does not impact the end-users who sell their existing house and reinvest in a new house. Those benefits remain.

While holding period hasn’t changed for property, it has changed from 36 months to 24 months for gold.

What it means for you: The removal of indexation benefit may be felt steeply in real estate depending on whether you made a lot of returns or otherwise. For those with poor returns, indexation would have helped even avoid tax. For those with very high returns (or very long holding period), this might turn out to be better tax treatment than the one with 20% indexation. For gold, the reduction of holding period from 36 to 24 is a plus. Mixed impact based on your gain!

The budget proposed doubling the STT on both futures and options contracts.

Futures contract rates have increased from 0.0125% to 0.02% of the traded value. Options contracts rates have been Increased from 0.0625% to 0.1% of the option premium. This amounts to a 60% increase for both. But it is noteworthy that exchanges like the NSE had announced a reduction in exchange transaction charges effective April 2024, across cash and derivatives. So some parts of the market opine that the F&O STT hike is largely neutral. We do not yet have a view on this. However, what is clear is that the government (and also SEBI) is making moves to ensure that derivative trading is restricted to those with deep pockets.

Effective October 1, 2024, interest on your RBI Floating Rate Savings Bonds will be taxed if interest exceeds Rs 10,000 a year. Also, any G-Secs and State Development Loans (SDLs) notified in the Gazette will also be subject to such TDS. Interest on these instruments so far did not suffer TDS although they were taxed like any other interest income.

At present, TDS is deductible at 1% for sale of property exceeding Rs 50 lakh. The budget has provided clarification on TDS related to immovable property in situations with multiple buyers or sellers.

Previous interpretation:  There was confusion about whether TDS applied when the total sale consideration (price) exceeded ₹50 lakh but each individual buyer or seller's share was less than ₹50 lakh.

Budget 2024 clarification and amendment: The budget clarifies that TDS at 1% applies if the aggregate consideration (total sale price for all buyers and sellers combined) exceeds ₹50 lakh. This applies regardless of the amount paid by each individual buyer or received by each individual seller.

Simply put, if you're selling a property with multiple sellers or buyers, you need to consider the total sale price, not just each person's individual share, to determine if TDS applies.

Any amount received by you from a buyback of listed shares initiated by a company will be treated like dividends (other income) and taxed at your slab rate. However, the cost of such shares that you received as buyback can be set off against any other gain on the same shares in future. Example is given below:

What it means to you: After plugging the dividend distribution model used by promoters to take cash out, buybacks were a popular method to take out cash and distribute. With this proposal, such paybacks have been plugged. This means you might have fewer buybacks and you will need to assess whether it is attractive enough considering your tax outgo.

While this may not have a direct impact for you, the abolition of Angel tax can help entrepreneurs and the start-up ecosystem. Angel tax was the tax on investments received by startups from external investors. They were classified as income from other sources and taxed a rate of 30%, putting more burden on any young start-up. This change will be effective from April 1, 2025.

The finance minister also unveiled a new scheme called NPS Vatsalya under the National Pension Scheme (NPS) for minors, which offers parents and guardians the opportunity to start pension planning for their children by making contributions that will be transferred to the standard NPS when they turn 18. It may be too early to comment on this move but this is likely to be a better scheme (in terms of higher risk-return pay offs) than options like PPF, considering that the former is market linked. The lock-in, withdrawal, rebalance features etc. will determine whether it is worthwhile.

Budget 2024 – Impact on sectors and markets

The lower-than-expected fiscal deficit target of 4.9% for FY25 and unchanged capital expenditure may not be something for markets to rejoice as it broods higher capital gains and STT on futures and options. Nevertheless, the allocations indicate fiscal prudence and would likely be appreciated by the bond market.

We discussed about capital gains and their impact on your investments. Coming to the implication of the same on the market, this change is happening at a time when returns from equities as an asset class has been moderating over the past few years (even while there are bumper years). So, will equities remain attractive on a post-tax basis, especially for institutional investors who drive the market?

For foreign investors, currency depreciation can make this equation even worse (which has been the case between 2009 and 2020). The new capital gain rates are also coming at a time when markets are priced to perfection. So, any negative impact of this tax increase can also come to haunt the markets when expectation of growth cools-off at some point.

Meanwhile, the budget has also passed on taxation of buybacks in the hands of recipient (as dividend), which will put companies on a back foot. They cannot no longer easily reward investors when markets behave poorly.

On the positive side, the cheer for the market comes from fiscal consolidation, as rating agencies, bond markets and corporates will take the right cues from the same. While the fiscal deficit for FY24 itself came 0.2% lower than expected at 5.6%, the number for FY25 is pegged at 4.9% Vs market expectation of 5.1%.

The government has used better than expected tax collections and RBI dividend bounty to accelerate fiscal consolidation than tinkering too much with allocation. Besides, that we will have the next budget in a space of 6 months may have also kept the government from tinkering much with allocations. The few areas that saw allocation (money and space) was clean energy transition, innovation and R&D. Rest went to social development projects.

Another positive highlight in the budget was the government’s focus on employment creation with measures for employment and skilling the youth that would span over several years with a mammoth allocation of Rs 2 lakh crore. This includes incentive for employees and employers to absorb, skill and retain youth. This is something to be viewed as an initiative that would carry on in the coming years until it brings desired results. This also vindicates market’s assumption post the general election outcome that the government’s thrust could be changing towards employment creation, rural growth, etc.

Meanwhile, the FM has also tried to lure taxpayers to switch to “new tax scheme” by doling out higher standard deduction and lowering tax slab rates. What these would also result in is more money in the hands of people which can be positive for discretionary consumption. That is a sort of “trend” that developed post general election and would see it accelerating now.

  • It is the railway and defence pack from the PSU space that reacted most negatively to the budget. While the government’s capex commitment didn’t change vs. the interim budget at Rs.11.11 lakh crore, FM has specifically mentioned that the future allocation will be considering other priorities and fiscal consolidation as well. The fact that the Budget speech states the need for private sector to take over the mantle of capex forward is clearly communicative of this.
  • Markets should take comfort that the capex is still maintained high at 3.4% of GDP, but it may be the higher expectations that was causing negative reaction, combined with irrational valuations in these segments.
  • The stock of electronics manufacturing pioneer Dixon Tech fell after the Budget lowered duties on imported mobile phones and chargers from 20% to 15%. The government is perhaps of the view that the sector is approaching the desired scale and that it makes sense to lower the duty to where it was before the PLI incentives, where duty protection was given to help them scale.
  • On the positive side, Gold retailers got a shot in the arm with 9% reduction in customs duty on gold from 15% to 6% and this could not have come at a better time, just ahead of the festival season.  While this happened, Gold financiers witnessed a negative reaction as gold prices plunged, adversely affecting their loan to value (LTV) ratio.
  • ITC led the gains from heavyweights as the Budget spared smokers this time. The broader consumer sector and the IT sector gained in a weak market.
  • While these are but pockets of momentary market reaction, for us the accelerating trend in the consumption space, post elections, could have got a shot in the arm from the social measures in this Budget. Beyond that, there isn’t much to take home.

More like this

65 thoughts on “Budget 2024 – impact on your taxes, investments and markets”

  1. Madam, what about the exemptions u/s 80(g) for donations made to charitable organisations. Is it available under the new tax regime. Please clarify.

    1. I don’t think it is available. However, it is best to check with your tax consultant to know if there is any amendment on this. Vidya

  2. Hello Vidya Ma’am
    What will be the holding period cut-off for International ETFs to qualify as long term. 12 months or 24 months. Are they not listed securities.
    Thanks.

    1. Hello Sir, yes by that definition it is 12 months..while international funds will be 24 months. Since this seems too much of an arbitrage, we are hoping some clarity will emerge by Feb 25 (and these funds will move out of specified mutual fun definition only after April 1, 2025).Vidya

  3. Hello madam
    How is fund like icici asset allocator fundFOF bought before April 2023 taxed now & after April 2025
    Similarly Ppfas dynamic asset allocation fund
    After budget it seems to have lost indexn benefit but LTCG 12.5 % at 2 years
    Indexn benefit vs LTCG 12.5% on funds comparision
    Thanking you
    Regards

    1. if it is less than 65% debt (and not more than 65% in equity) – units bought before April 2023 will be taxed at slab now and at 12.5% after 2 years of holding eff April 1, 2025. Same for PPFAS if the above condition on holding is satisfied. There can be no comparison between indexation and without indexation since it will depend on 3 variables – holding period, inflation during that period and fund returns. Higher the returns (higher than inflation), 12.5% will be better. Returns lower than inflation – indexation will be better.

  4. Business today has quoted you on the personal finance page today. Next to that is an article by Mr Harsh Roongta. That article suggests that any gain in equity/ equity MF after 31/1/2018 will be taxed at 12.5% if sold today. Is that correct understanding? Surprised that many people are not talking about it although this is almost like a retrospective tax!

    1. There is no change there and hence not talked about. The cut off of Jan 31, 2018 prevails for valuation of revised cost of acquisition – not for rates. Rates are the latest announced. for all equity. Thanks, Vidya

  5. Excellent summary of the budget tax changes .
    Since international funds now qualify for LTCG of 12.5 % , will appreciate if you can update the list of schemes where lumpsum investments are still open,as earlier due to RBI limits many had stopped taking new subscriptions

    1. Thanks!
      Understand your need but such a list has become difficult as funds are constantly changing on whether they are available for lumpsum/SIP or none. it is best to check with the platform you are investing in. thanks. Vidya

  6. Excellent summary of the budget tax changes

    Since international funds now qualify for LTCG of 12.5 % , will appreciate if you can update the list of schemes where lumpsum investments are still open,as earlier due to RBI limits many had stopped taking new subscriptions

  7. Hello Ma’am,
    I have investments in gold mutual funds which are more than 3 years old ( also bought before 1st April 2023 ). If I redeem today how are the gains going to be taxed. Will they be added to my income and taxed at slab rates or at 20% with indexation because you saying the proposed tax changes ( LTCG 12.5% ) are going to be effective from 1st April 2025.
    Thanks.

    1. If you sell before April 1, 2025 (for units bought before April 1, 2023), you will receive indexation and 20% rate. if you sell after April 1, 2025, they will be taxed at 12.5% Vidya

      1. Vidya Mam, is the clarification you gave for gold MF purchased before 1 April 2023… also valid for debt & conservative hybrid funds? What if these funds purchased before 1 April 2023 would not complete 3 years but complete 2 years since purchase?

        1. If debt funds are bought before April 2023 and completed 3 years, and sold before April 1, 2025, indexation with 20% in applicable.If they completed 3 years are sold after April 1, 2025, then 12.5% will apply (only for units bought before April 1, 2023). For units bought before April 1, 2023 and sold within 2 years, slab rate will apply.

      2. Most mutual funds are saying that you will be taxed at 12.5% without indexation even if you sell before April 1, 2025 as long as it is LTCG – and LTCG is after 24 months. Please re-check

        1. Yes,you are right. I have given clarificatory comments post our initial understanding. So there is no grandfathering in the true sense. You just get better treatment with 2 year cut off and 12.5% thanks, Vidya

    2. Hello Sir, further to my earlier comment – I have to clarify that there will be no indexation for units bought before April 1, 2023, as stated by me. We have clarification from MFs, that it will be 12.5% after 2 years. This is true for units of debt funds, international funds or gold funds bought before April 1, 2023.

Comments are closed.

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

Have an account?
Login To Your Account
OR

Don’t have an account ? Register for free